Researchers at the Wellcome Sanger Institute have found that Clostridium difficile is evolving into two different species, one that has adapted to spread in hospital settings.
Researchers with the Wellcome Sanger Institute have published a study that reinforces that hospitals are the primary source for multidrug-resistant pathogens. The results highlight the threat of carbapenem resistance, one of the most powerful antibiotics used in hospitals.
Researchers from McMaster University have manufactured a new antibacterial gel consisting entirely of bacteria-killing viruses. The new gel opens new doors for phage research in the era of antimicrobial resistance.
Multi-drug resistant E. coli strains were found in healthy women showing no symptoms of urinary tract infections. This led researchers to reevaluate the clinical significance of bacteria in urine without symptoms and the possibility of pandemic strains.
The Indian government has banned the use of “last hope” antibiotics on farms. This article chronicles the events leading up the ban, as well as their own investigative story into Indian farms that revealed the wide use of these antibiotics to fatten livestock.
A study by University of Plymouth researchers suggests that standard disinfectants used by hospitals may no longer be effective in preventing the spread of Clostridioides difficile.
This document outlines how Wawles will address the risks of the development and spread of antimicrobial resistance in animals and the environment. It discusses best agriculture best practices that align with antimicrobial stewardship.
The Welsh government released a five-year plan to decrease antimicrobial resistance in their livestock population. With an emphasis on prevention and judicious use of antimicrobials, the Welsh government aims to use antimicrobials wisely to preserve their effectiveness.
A team led by Case Western University School of Medicine demonstrated in mouse models that a “mechanism-based approach” to combination chemotherapy shows potential for treating multidrug-resistant Pseudomonas aeruginosa.
Tajikistan is the first country in the Europe and Central Asia region to conduct pilot tests of the Progressive Management Pathway for antimicrobial resistance. The tool self-assessment tool provides guidance for countries in developing and implementing a One Health national action plan.